These VLDLs and their remnant particles enriched in apolipoprotein E and apolipoprotein C-III (apoC-III) may retain in the arterial wall, contributing to the initiation and progression of atherosclerosis, vascular inflammation, and prothrombotic effects [19]. This evidence concerns the gene APOC3 and atherosclerosis.